52-week Data: Litifilimab Shows Durable Skin Clearance in Cutaneous Lupus

Litifilimab (Biogen) produces “rapid and durable” efficacy in cutaneous lupus erythematosus (CLE), according to 52-week results from the Phase 2 part of the ongoing AMETHYST Phase 2/3 study (Part A).